Matches in SemOpenAlex for { <https://semopenalex.org/work/W29948512> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W29948512 endingPage "645" @default.
- W29948512 startingPage "641" @default.
- W29948512 abstract "Acinetobacter baumannii is a frequent cause of nosocomial infections in most hospitals. Management of infections caused by these strains is difficult, as the strains often display multiple drug resistance, including carbapenem. Tigecycline which is a glycylcycline derivative has antimicrobial activity against many gram-positive and gram-negative organisms. In this study, in vitro activity of tigecycline and carbapenems against clinical isolates of A.baumannii strains were investigated. A total of 100 A.baumannii isolates were collected from hospitalized patients with documented nosocomial infections [pneumonia (n = 39), surgical wound infection (n = 32), bacteremia (n = 16), catheter infection (n = 6), urinary tract infection (n = 5), peritonitis (n = 1), eye infection (n = 1)] between October 2006 and June 2007. Only one isolate per patient was included to the study. Minimum inhibitory concentrations (MIC) of tigecycline were determined by E-test (AB Biodisk, Sweden). Carbapenem resistance of A.baumannii strains were determined by disk diffusion method. All of the 100 A.baumannii isolates (100%) were found susceptible to tigecycline (MIC values ≤ 2 µg/ml; MIC ranges: 0.032-1.5 µg/ml). Imipenem susceptibility test was performed for 95 strains, and 36 (37.9%) were found sensitive, 18 (18.9%) were intermediate sensitive, and 41 (43.2%) were resistant. Meropenem susceptibility test was performed for 87 strains, and 22 (25.3%) were found sensitive, 9 (10.3%) were intermediate sensitive, and 56 (64.4%) were resistant. Since tigecycline is found quite effective on nosocomial A.baumannii isolates, it may be considered as a treatment alternative in infections caused by carbapenem-resistant Acinetobacter spp." @default.
- W29948512 created "2016-06-24" @default.
- W29948512 creator A5047219782 @default.
- W29948512 creator A5047479680 @default.
- W29948512 creator A5049868345 @default.
- W29948512 creator A5059313167 @default.
- W29948512 creator A5061508370 @default.
- W29948512 creator A5069718518 @default.
- W29948512 date "2010-10-01" @default.
- W29948512 modified "2023-09-26" @default.
- W29948512 title "In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates" @default.
- W29948512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21063976" @default.
- W29948512 hasPublicationYear "2010" @default.
- W29948512 type Work @default.
- W29948512 sameAs 29948512 @default.
- W29948512 citedByCount "2" @default.
- W29948512 countsByYear W299485122014 @default.
- W29948512 countsByYear W299485122022 @default.
- W29948512 crossrefType "journal-article" @default.
- W29948512 hasAuthorship W29948512A5047219782 @default.
- W29948512 hasAuthorship W29948512A5047479680 @default.
- W29948512 hasAuthorship W29948512A5049868345 @default.
- W29948512 hasAuthorship W29948512A5059313167 @default.
- W29948512 hasAuthorship W29948512A5061508370 @default.
- W29948512 hasAuthorship W29948512A5069718518 @default.
- W29948512 hasConcept C2776315533 @default.
- W29948512 hasConcept C2776685102 @default.
- W29948512 hasConcept C2777027569 @default.
- W29948512 hasConcept C2777637488 @default.
- W29948512 hasConcept C2778523567 @default.
- W29948512 hasConcept C2779375183 @default.
- W29948512 hasConcept C2779631663 @default.
- W29948512 hasConcept C501593827 @default.
- W29948512 hasConcept C523546767 @default.
- W29948512 hasConcept C54355233 @default.
- W29948512 hasConcept C71924100 @default.
- W29948512 hasConcept C86803240 @default.
- W29948512 hasConcept C89423630 @default.
- W29948512 hasConcept C94665300 @default.
- W29948512 hasConceptScore W29948512C2776315533 @default.
- W29948512 hasConceptScore W29948512C2776685102 @default.
- W29948512 hasConceptScore W29948512C2777027569 @default.
- W29948512 hasConceptScore W29948512C2777637488 @default.
- W29948512 hasConceptScore W29948512C2778523567 @default.
- W29948512 hasConceptScore W29948512C2779375183 @default.
- W29948512 hasConceptScore W29948512C2779631663 @default.
- W29948512 hasConceptScore W29948512C501593827 @default.
- W29948512 hasConceptScore W29948512C523546767 @default.
- W29948512 hasConceptScore W29948512C54355233 @default.
- W29948512 hasConceptScore W29948512C71924100 @default.
- W29948512 hasConceptScore W29948512C86803240 @default.
- W29948512 hasConceptScore W29948512C89423630 @default.
- W29948512 hasConceptScore W29948512C94665300 @default.
- W29948512 hasIssue "4" @default.
- W29948512 hasLocation W299485121 @default.
- W29948512 hasLocation W299485122 @default.
- W29948512 hasOpenAccess W29948512 @default.
- W29948512 hasPrimaryLocation W299485121 @default.
- W29948512 hasRelatedWork W2007434189 @default.
- W29948512 hasRelatedWork W2097481938 @default.
- W29948512 hasRelatedWork W2153125923 @default.
- W29948512 hasRelatedWork W2236891572 @default.
- W29948512 hasRelatedWork W2305468557 @default.
- W29948512 hasRelatedWork W2345295800 @default.
- W29948512 hasRelatedWork W2355748644 @default.
- W29948512 hasRelatedWork W2368465646 @default.
- W29948512 hasRelatedWork W2370347761 @default.
- W29948512 hasRelatedWork W2385253098 @default.
- W29948512 hasRelatedWork W2431895615 @default.
- W29948512 hasRelatedWork W2735551568 @default.
- W29948512 hasRelatedWork W2744725696 @default.
- W29948512 hasRelatedWork W2791898933 @default.
- W29948512 hasRelatedWork W2799903060 @default.
- W29948512 hasRelatedWork W3030851750 @default.
- W29948512 hasRelatedWork W2108324997 @default.
- W29948512 hasRelatedWork W2184046824 @default.
- W29948512 hasRelatedWork W2535496287 @default.
- W29948512 hasRelatedWork W2810825642 @default.
- W29948512 hasVolume "44" @default.
- W29948512 isParatext "false" @default.
- W29948512 isRetracted "false" @default.
- W29948512 magId "29948512" @default.
- W29948512 workType "article" @default.